Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV

被引：0

作者：

Anton Pozniak ^{[1
]}

Chloe Orkin ^{[2
]}

Yazdan Yazdanpanah ^{[3
]}

Axel Baumgarten ^{[4
]}

Karam Mounzer ^{[5
]}

Michelle L. D’Antoni ^{[6
]}

Hailin Huang ^{[6
]}

Hui Liu ^{[6
]}

Kristen Andreatta ^{[6
]}

Laurie A. VanderVeen ^{[6
]}

Christian Callebaut ^{[6
]}

Jason T. Hindman ^{[6
]}

José R. Arribas ^{[7
]}

机构：

[1] Chelsea and Westminster Hospital NHS Foundation Trust,

[2] Queen Mary University of London,undefined

[3] AP-HP Hôpital Bichat,undefined

[4] Center for Infectious Diseases,undefined

[5] Philadelphia FIGHT,undefined

[6] Gilead Sciences,undefined

[7] Inc.,undefined

[8] Hospital Universitario La Paz,undefined

[9] Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC),undefined

来源：

Infectious Diseases and Therapy | 2025年 / 14卷 / 6期

关键词：

Adherence; Antiretroviral therapy; Bictegravir/emtricitabine/tenofovir alafenamide; Genotype analysis; Human immunodeficiency virus; Virologic suppression;

D O I：

10.1007/s40121-025-01153-y

中图分类号：

学科分类号：

摘要：

引用

页码：1201 / 1217

页数：16